SLC2A4 and metabolic syndrome: Hyperglycemia, a key outcome of metabolic syndrome, was ameliorated in synbiotic + HFD animals along with reduced insulin level suggesting improved glucose metabolism which might be due to alleviated β cell dysfunction, increased expression of GLUT-4 leading to increased glucose uptake by adipose tissue and muscles21–23.